On Demand

Prof Roy Fleischmann: ORAL Strategy trial

Prof Fleischmann

Professor Fleischmann's summary of the methodology of the ORAL Strategy trial and presentation of the results.

On Demand

Prof Rieke Alten: Unmet needs and patient reported outcomes

Prof Alten

Professor Alten discusses the state of unmet needs of rheumatoid arthitis sufferers, and the patient-reported outcomes from the tofacitinib phase III trials.

On Demand

Dr Peter Nash: long term safety data

Dr Nash

Dr Nash provides insights into the XELJANZ Mode of Action, key patient clinical measures used in his daily practice and the important patient outcomes that are focused on.

On Demand

Prof Janet Pope: reaction to Xeljanz symposium

Prof Pope

Professor Pope discusses the key take home messages on the latest JAK inhibitor data from the Pfizer RA symposium at EULAR, and the implications this data has for clinical management of RA patients.

On Demand

Dr Eduardo Mysler: onset of action and sustained efficacy

Dr Mysler

Dr Eduardo Mysler discusses the onset of action and sustained efficacy

Ultibro video resources_Pfizer for Professionals
On Demand

ERS 2017 with Laura Rush - The impact of COPD on quality of life

Laura Rush - Respiratory Lead Practice Nurse

Laura Rush Respiratory Lead Practice Nurse

Ultibro Breezhaler prescribing information
Seebri Breezhaler prescribing information

OVERVIEW:

Practice nurse, Laura Rush, discusses the impact of COPD symptoms on quality of life (HRQoL) in patients with COPD

Ultibro video resources_Pfizer for Professionals
On Demand

ERS 2017 with Darush Attar-Zadeh - A cost effective approach to symptomatic maintenance treatment of COPD

Darush Attar-Zadeh - Respiratory Lead Pharmacist

Darush Attar

Ultibro Breezhaler prescribing information
Seebri Breezhaler prescribing information

OVERVIEW:

Pharmacist, Darush Attar-Zedah, discusses recent LABA/LAMA data presented at ERS.

Ultibro video resources_Pfizer for Professionals
On Demand

ERS 2017 with Dr Richard Russell - Balancing benefit with risk in COPD, an evidence based perspective

Dr Richard Russell - Respiratory Consultant

Dr Richard Russell

Ultibro Breezhaler prescribing information
Seebri Breezhaler prescribing information

OVERVIEW:

Dr Richard Russell gives an overview of some of the recent Ultibro® Breezhaler® clinical trial data presented at ERS.

Ultibro video resources_Pfizer for Professionals
On Demand

ERS 2017 with Dr Amanda Harry - Evaluating outcomes across COPD disease severities

Dr Amanda Harry - General Practitioner

Dr amanda Harry

Ultibro Breezhaler prescribing information
Seebri Breezhaler prescribing information

OVERVIEW:

Dr Amanda Harry gives an overview of some of the recent Ultibro® Breezhaler® clinical trial data presented at ERS

Ultibro video resources_Pfizer for Professionals
On Demand

ERS 2017 with Helena Cummings - A primary care perspective on blood eosinophils as a biomarker in COPD

Helena Cummings - Specialist Respiratory Nurse

Helena Cummings Senior Respiratory Nurse

Ultibro Breezhaler prescribing information
Seebri Breezhaler prescribing information

OVERVIEW:

Helena Cummings discusses understanding the role of eosinophils in primary care management of COPD